Paragon 28, Inc. (FNA)

USD 10.04

(-3.09%)

Gross Profit Summary of Paragon 28, Inc.

  • Paragon 28, Inc.'s latest annual gross profit in 2023 was 172.79 Million USD , up 5.59% from previous year.
  • Paragon 28, Inc.'s latest quarterly gross profit in 2024 Q2 was 41.14 Million USD , down -6.42% from previous quarter.
  • Paragon 28, Inc. reported a annual gross profit of 148.92 Million USD in annual gross profit 2022, up 24.69% from previous year.
  • Paragon 28, Inc. reported a annual gross profit of 119.44 Million USD in annual gross profit 2021, up 39.07% from previous year.
  • Paragon 28, Inc. reported a quarterly gross profit of 48.89 Million USD for 2024 Q1, up 21.69% from previous quarter.
  • Paragon 28, Inc. reported a quarterly gross profit of 42.38 Million USD for 2023 Q3, up 0.56% from previous quarter.

Annual Gross Profit Chart of Paragon 28, Inc. (2023 - 2019)

Historical Annual Gross Profit of Paragon 28, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 172.79 Million USD 5.59%
2022 148.92 Million USD 24.69%
2021 119.44 Million USD 39.07%
2020 85.88 Million USD -1.79%
2019 87.44 Million USD 0.0%

Peer Gross Profit Comparison of Paragon 28, Inc.

Name Gross Profit Gross Profit Difference
Abbott Laboratories 22.13 Billion USD 99.219%
Allurion Technologies Inc. 41.49 Million USD -316.394%
Artivion, Inc. 229.17 Million USD 24.603%
Avanos Medical, Inc. 379.7 Million USD 54.493%
Butterfly Network, Inc. 16.85 Million USD -925.101%
Butterfly Network, Inc. 16.85 Million USD -925.101%
Bio-Rad Laboratories, Inc. 1.43 Billion USD 87.928%
Boston Scientific Corporation 9.89 Billion USD 98.254%
Perspective Therapeutics, Inc. 1.63 Million USD -10474.725%
CONMED Corporation 643.06 Million USD 73.13%
Edwards Lifesciences Corporation 4.62 Billion USD 96.264%
Glaukos Corporation 239.13 Million USD 27.744%
Globus Medical, Inc. 1.02 Billion USD 83.065%
Inspire Medical Systems, Inc. 528.22 Million USD 67.288%
Integer Holdings Corporation 418.28 Million USD 58.691%
Medtronic plc 19.45 Billion USD 99.112%
Nevro Corp. 290.06 Million USD 40.429%
Owlet, Inc. 22.58 Million USD -665.002%
Penumbra, Inc. 682.64 Million USD 74.688%
Vicarious Surgical Inc. -1.85 Million USD 9419.903%
Smith & Nephew plc 3.7 Billion USD 95.331%
Sonendo, Inc. 10.72 Million USD -1511.556%
STERIS plc 2.23 Billion USD 92.265%
Stryker Corporation 13.05 Billion USD 98.677%
Vapotherm, Inc. 28.28 Million USD -510.936%
Zimmer Biomet Holdings, Inc. 5.31 Billion USD 96.746%